Clinical Trial Update: Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial Dragon III compares neoadjuvant FLOT versus SOX in gastric cancer; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastric Cancer, Chemotherapy Effect | Phase 2 | Status: COMPLETED | Results posted: 2020-06-22